Clolar (sanofi-aventis U.S. LLC)
Welcome to the PulseAid listing for the Clolar drug offered from sanofi-aventis U.S. LLC. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | sanofi-aventis U.S. LLC |
NON-PROPRIETARY NAME: | clofarabine |
SUBSTANCE NAME: | CLOFARABINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2013-04-01 |
END MARKETING DATE: | 0000-00-00 |
Clolar HUMAN PRESCRIPTION DRUG Details:
Item Description | Clolar from sanofi-aventis U.S. LLC |
LABELER NAME: | sanofi-aventis U.S. LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/mL) |
START MARKETING DATE: | 2013-04-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0024-5860_84e0d5b2-8c35-487f-af64-7198a124c632 |
PRODUCT NDC: | 0024-5860 |
APPLICATION NUMBER: | NDA021673 |
Other CLOFARABINE Pharmaceutical Manufacturers / Labelers: